{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:14:01Z","timestamp":1787494441979,"version":"build-2736575974"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,12,7]],"date-time":"2017-12-07T00:00:00Z","timestamp":1512604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,12,7]],"date-time":"2017-12-07T00:00:00Z","timestamp":1512604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)\/Cas9 system revolutionized the field of gene editing but viral delivery of the CRISPR\/Cas9 system has not been fully explored. Here we adapted clinically relevant high-capacity adenoviral vectors (HCAdV) devoid of all viral genes for the delivery of the CRISPR\/Cas9 machinery using a single viral vector. We present a platform enabling fast transfer of the Cas9 gene and gRNA expression units into the HCAdV genome including the option to choose between constitutive or inducible Cas9 expression and gRNA multiplexing. Efficacy and versatility of this pipeline was exemplified by producing different CRISPR\/Cas9-HCAdV targeting the human papillomavirus (HPV) 18 oncogene\n                    <jats:italic>E6<\/jats:italic>\n                    , the dystrophin gene causing Duchenne muscular dystrophy (DMD) and the HIV co-receptor C-C chemokine receptor type 5 (CCR5). All CRISPR\/Cas9-HCAdV proved to be efficient to deliver the respective CRISPR\/Cas9 expression units and to introduce the desired DNA double strand breaks at their intended target sites in immortalized and primary cells.\n                  <\/jats:p>","DOI":"10.1038\/s41598-017-17180-w","type":"journal-article","created":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T04:54:37Z","timestamp":1512104077000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":86,"title":["CRISPR\/Cas9 delivery with one single adenoviral vector devoid of all viral genes"],"prefix":"10.1038","volume":"7","author":[{"given":"Eric","family":"Ehrke-Schulz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maren","family":"Schiwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theo","family":"Leitner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"D\u00e1vid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Bergmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Ehrhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,7]]},"reference":[{"key":"17180_CR1","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1126\/science.1225829","volume":"337","author":"M Jinek","year":"2012","unstructured":"Jinek, M. et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science \n                           337, 816\u2013821 (2012).","journal-title":"Science"},{"key":"17180_CR2","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/mt.2016.10","volume":"24","author":"ML Maeder","year":"2016","unstructured":"Maeder, M. L. & Gersbach, C. A. Genome-editing Technologies for Gene and Cell Therapy. Molecular therapy: the journal of the American Society of Gene Therapy \n                           24, 430\u2013446 (2016).","journal-title":"Molecular therapy: the journal of the American Society of Gene Therapy"},{"key":"17180_CR3","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1002\/biot.201400046","volume":"9","author":"E Senis","year":"2014","unstructured":"Senis, E. et al. CRISPR\/Cas9-mediated genome engineering: an adeno-associated viral (AAV) vector toolbox. Biotechnology journal \n                           9, 1402\u20131412 (2014).","journal-title":"Biotechnology journal"},{"key":"17180_CR4","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nbt.3055","volume":"33","author":"L Swiech","year":"2015","unstructured":"Swiech, L. et al. In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9. Nature biotechnology \n                           33, 102\u2013106 (2015).","journal-title":"Nature biotechnology"},{"key":"17180_CR5","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/biot.201400529","volume":"10","author":"F Schmidt","year":"2015","unstructured":"Schmidt, F. & Grimm, D. CRISPR genome engineering and viral gene delivery: a case of mutual attraction. Biotechnology journal \n                           10, 258\u2013272 (2015).","journal-title":"Biotechnology journal"},{"key":"17180_CR6","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1093\/nar\/gku749","volume":"42","author":"AM Kabadi","year":"2014","unstructured":"Kabadi, A. M., Ousterout, D. G., Hilton, I. B. & Gersbach, C. A. Multiplex CRISPR\/Cas9-based genome engineering from a single lentiviral vector. Nucleic acids research \n                           42, e147 (2014).","journal-title":"Nucleic acids research"},{"key":"17180_CR7","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.cell.2014.09.014","volume":"159","author":"RJ Platt","year":"2014","unstructured":"Platt, R. J. et al. CRISPR-Cas9 knockin mice for genome editing and cancer modeling. Cell \n                           159, 440\u2013455 (2014).","journal-title":"Cell"},{"key":"17180_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/srep05105","volume":"4","author":"I Maggio","year":"2014","unstructured":"Maggio, I. et al. Adenoviral vector delivery of RNA-guided CRISPR\/Cas9 nuclease complexes induces targeted mutagenesis in a diverse array of human cells. Scientific reports \n                           4, 5105 (2014).","journal-title":"Scientific reports"},{"key":"17180_CR9","doi-asserted-by":"publisher","first-page":"e1004090","DOI":"10.1371\/journal.ppat.1004090","volume":"10","author":"Y Bi","year":"2014","unstructured":"Bi, Y. et al. High-efficiency targeted editing of large viral genomes by RNA-guided nucleases. PLoS pathogens \n                           10, e1004090 (2014).","journal-title":"PLoS pathogens"},{"key":"17180_CR10","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1099\/vir.0.000139","volume":"96","author":"C Li","year":"2015","unstructured":"Li, C. et al. Inhibition of HIV-1 infection of primary CD4+ T-cells by gene editing of CCR5 using adenovirus-delivered CRISPR\/Cas9. J Gen Virol \n                           96, 2381\u20132393 (2015).","journal-title":"J Gen Virol"},{"key":"17180_CR11","doi-asserted-by":"publisher","first-page":"3954","DOI":"10.1016\/j.febslet.2014.09.008","volume":"588","author":"R Cheng","year":"2014","unstructured":"Cheng, R. et al. Efficient gene editing in adult mouse livers via adenoviral delivery of CRISPR\/Cas9. FEBS letters \n                           588, 3954\u20133958 (2014).","journal-title":"FEBS letters"},{"key":"17180_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/srep37051","volume":"6","author":"I Maggio","year":"2016","unstructured":"Maggio, I., Liu, J., Janssen, J. M., Chen, X. & Goncalves, M. A. Adenoviral vectors encoding CRISPR\/Cas9 multiplexes rescue dystrophin synthesis in unselected populations of DMD muscle cells. Sci Rep \n                           6, 37051 (2016).","journal-title":"Sci Rep"},{"key":"17180_CR13","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/mt.2015.192","volume":"24","author":"L Xu","year":"2016","unstructured":"Xu, L. et al. CRISPR-mediated Genome Editing Restores Dystrophin Expression and Function in mdx Mice. Mol Ther \n                           24, 564\u2013569 (2016).","journal-title":"Mol Ther"},{"key":"17180_CR14","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1089\/hum.2015.087","volume":"26","author":"D Wang","year":"2015","unstructured":"Wang, D. et al. Adenovirus-Mediated Somatic Genome Editing of Pten by CRISPR\/Cas9 in Mouse Liver in Spite of Cas9-Specific Immune Responses. Human gene therapy \n                           26, 432\u2013442 (2015).","journal-title":"Human gene therapy"},{"key":"17180_CR15","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1038\/sj.gt.3302316","volume":"11","author":"J Tang","year":"2004","unstructured":"Tang, J. et al. Adenovirus hexon T-cell epitope is recognized by most adults and is restricted by HLA DP4, the most common class II allele. Gene therapy \n                           11, 1408\u20131415 (2004).","journal-title":"Gene therapy"},{"key":"17180_CR16","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1089\/hum.1998.9.10-1419","volume":"9","author":"CA Smith","year":"1998","unstructured":"Smith, C. A., Woodruff, L. S., Rooney, C. & Kitchingman, G. R. Extensive cross-reactivity of adenovirus-specific cytotoxic T cells. Human gene therapy \n                           9, 1419\u20131427 (1998).","journal-title":"Human gene therapy"},{"key":"17180_CR17","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.vaccine.2009.10.145","volume":"28","author":"TC Mast","year":"2010","unstructured":"Mast, T. C. et al. International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: correlates of high Ad5 titers and implications for potential HIV vaccine trials. Vaccine \n                           28, 950\u2013957 (2010).","journal-title":"Vaccine"},{"key":"17180_CR18","doi-asserted-by":"publisher","first-page":"13565","DOI":"10.1073\/pnas.93.24.13565","volume":"93","author":"RJ Parks","year":"1996","unstructured":"Parks, R. J. et al. A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal. Proceedings of the National Academy of Sciences of the United States of America \n                           93, 13565\u201313570 (1996).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"17180_CR19","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/ng0298-180","volume":"18","author":"G Schiedner","year":"1998","unstructured":"Schiedner, G. et al. Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Nature genetics \n                           18, 180\u2013183 (1998).","journal-title":"Nature genetics"},{"key":"17180_CR20","doi-asserted-by":"publisher","first-page":"3923","DOI":"10.1182\/blood.V99.11.3923","volume":"99","author":"A Ehrhardt","year":"2002","unstructured":"Ehrhardt, A. & Kay, M. A. A new adenoviral helper-dependent vector results in long-term therapeutic levels of human coagulation factor IX at low doses in vivo. Blood \n                           99, 3923\u20133930 (2002).","journal-title":"Blood"},{"key":"17180_CR21","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1089\/hum.2009.020","volume":"20","author":"L Jager","year":"2009","unstructured":"Jager, L. & Ehrhardt, A. Persistence of high-capacity adenoviral vectors as replication-defective monomeric genomes in vitro and in murine liver. Human gene therapy \n                           20, 883\u2013896 (2009).","journal-title":"Human gene therapy"},{"key":"17180_CR22","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1093\/nar\/gkv031","volume":"43","author":"M Muck-Hausl","year":"2015","unstructured":"Muck-Hausl, M., Solanki, M., Zhang, W., Ruzsics, Z. & Ehrhardt, A. Ad 2.0: a novel recombineering platform for high-throughput generation of tailored adenoviruses. Nucleic acids research \n                           43, e50 (2015).","journal-title":"Nucleic acids research"},{"key":"17180_CR23","doi-asserted-by":"publisher","first-page":"14057","DOI":"10.1038\/mtm.2014.57","volume":"1","author":"K Saydaminova","year":"2015","unstructured":"Saydaminova, K. et al. Efficient genome editing in hematopoietic stem cells with helper-dependent Ad5\/35 vectors expressing site-specific endonucleases under microRNA regulation. Molecular Therapy \u2014 Methods & Clinical Development \n                           1, 14057 (2015).","journal-title":"Molecular Therapy \u2014 Methods & Clinical Development"},{"key":"17180_CR24","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1089\/hum.2010.245","volume":"22","author":"SJ Gray","year":"2011","unstructured":"Gray, S. J. et al. Optimizing promoters for recombinant adeno-associated virus-mediated gene expression in the peripheral and central nervous system using self-complementary vectors. Human gene therapy \n                           22, 1143\u20131153 (2011).","journal-title":"Human gene therapy"},{"key":"17180_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6750-10-81","volume":"10","author":"R Loew","year":"2010","unstructured":"Loew, R., Heinz, N., Hampf, M., Bujard, H. & Gossen, M. Improved Tet-responsive promoters with minimized background expression. BMC biotechnology \n                           10, 81 (2010).","journal-title":"BMC biotechnology"},{"key":"17180_CR26","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1038\/sj.gt.3302780","volume":"13","author":"X Zhou","year":"2006","unstructured":"Zhou, X., Vink, M., Klaver, B., Berkhout, B. & Das, A. T. Optimization of the Tet-On system for regulated gene expression through viral evolution. Gene therapy \n                           13, 1382\u20131390 (2006).","journal-title":"Gene therapy"},{"key":"17180_CR27","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1093\/nar\/gkt1339","volume":"42","author":"H Wang","year":"2014","unstructured":"Wang, H. et al. Improved seamless mutagenesis by recombineering using ccdB for counterselection. Nucleic Acids Res \n                           42, e37 (2014).","journal-title":"Nucleic Acids Res"},{"key":"17180_CR28","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1016\/j.celrep.2017.05.008","volume":"19","author":"W Zhang","year":"2017","unstructured":"Zhang, W. et al. An Engineered Virus Library as a Resource for the Spectrum-wide Exploration of Virus and Vector Diversity. Cell Rep \n                           19, 1698\u20131709 (2017).","journal-title":"Cell Rep"},{"key":"17180_CR29","doi-asserted-by":"publisher","first-page":"11965","DOI":"10.1128\/JVI.01879-14","volume":"88","author":"EM Kennedy","year":"2014","unstructured":"Kennedy, E. M. et al. Inactivation of the human papillomavirus E6 or E7 gene in cervical carcinoma cells by using a bacterial CRISPR\/Cas RNA-guided endonuclease. J Virol \n                           88, 11965\u201311972 (2014).","journal-title":"J Virol"},{"key":"17180_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7244","volume":"6","author":"DG Ousterout","year":"2015","unstructured":"Ousterout, D. G. et al. Multiplex CRISPR\/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophy. Nature communications \n                           6, 6244 (2015).","journal-title":"Nature communications"},{"key":"17180_CR31","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nprot.2009.4","volume":"4","author":"L Jager","year":"2009","unstructured":"Jager, L. et al. A rapid protocol for construction and production of high-capacity adenoviral vectors. Nature protocols \n                           4, 547\u2013564 (2009).","journal-title":"Nature protocols"},{"key":"17180_CR32","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.ymthe.2003.08.014","volume":"8","author":"D Palmer","year":"2003","unstructured":"Palmer, D. & Ng, P. Improved system for helper-dependent adenoviral vector production. Molecular therapy: the journal of the American Society of Gene Therapy \n                           8, 846\u2013852 (2003).","journal-title":"Molecular therapy: the journal of the American Society of Gene Therapy"},{"key":"17180_CR33","doi-asserted-by":"crossref","unstructured":"Ehrke-Schulz, E. et al. Cloning and Large-Scale Production of High-Capacity Adenoviral Vectors Based on the Human Adenovirus Type 5. J Vis Exp, e52894 (2016).","DOI":"10.3791\/52894"},{"key":"17180_CR34","doi-asserted-by":"publisher","first-page":"16039","DOI":"10.1038\/mtm.2016.39","volume":"3","author":"DJ Palmer","year":"2016","unstructured":"Palmer, D. J., Grove, N. C. & Ng, P. Helper virus-mediated downregulation of transgene expression permits production of recalcitrant helper-dependent adenoviral vector. Mol Ther Methods Clin Dev \n                           3, 16039 (2016).","journal-title":"Mol Ther Methods Clin Dev"},{"key":"17180_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/srep05400","volume":"4","author":"T Sakuma","year":"2014","unstructured":"Sakuma, T., Nishikawa, A., Kume, S., Chayama, K. & Yamamoto, T. Multiplex genome engineering in human cells using all-in-one CRISPR\/Cas9 vector system. Scientific reports \n                           4, 5400 (2014).","journal-title":"Scientific reports"},{"key":"17180_CR36","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.antiviral.2015.10.004","volume":"123","author":"EM Kennedy","year":"2015","unstructured":"Kennedy, E. M., Kornepati, A. V. & Cullen, B. R. Targeting hepatitis B virus cccDNA using CRISPR\/Cas9. Antiviral Res \n                           123, 188\u2013192 (2015).","journal-title":"Antiviral Res"},{"key":"17180_CR37","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ymeth.2015.08.012","volume":"91","author":"EM Kennedy","year":"2015","unstructured":"Kennedy, E. M. et al. Optimization of a multiplex CRISPR\/Cas system for use as an antiviral therapeutic. Methods \n                           91, 82\u201386 (2015).","journal-title":"Methods"},{"key":"17180_CR38","unstructured":"Nelson, C. E. et al. In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy. Science, (2015)."},{"key":"17180_CR39","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1126\/science.aad5725","volume":"351","author":"C Long","year":"2016","unstructured":"Long, C. et al. Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy. Science \n                           351, 400\u2013403 (2016).","journal-title":"Science"},{"key":"17180_CR40","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/nature14299","volume":"520","author":"FA Ran","year":"2015","unstructured":"Ran, F. A. et al. In vivo genome editing using Staphylococcus aureus Cas9. Nature \n                           520, 186\u2013191 (2015).","journal-title":"Nature"},{"key":"17180_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-015-0817-8","volume":"16","author":"AE Friedland","year":"2015","unstructured":"Friedland, A. E. et al. Characterization of Staphylococcus aureus Cas9: a smaller Cas9 for all-in-one adeno-associated virus delivery and paired nickase applications. Genome biology \n                           16, 257 (2015).","journal-title":"Genome biology"},{"key":"17180_CR42","doi-asserted-by":"publisher","first-page":"222","DOI":"10.2174\/156652308785160647","volume":"8","author":"MM Segura","year":"2008","unstructured":"Segura, M. M., Alba, R., Bosch, A. & Chillon, M. Advances in helper-dependent adenoviral vector research. Current gene therapy \n                           8, 222\u2013235 (2008).","journal-title":"Current gene therapy"},{"key":"17180_CR43","doi-asserted-by":"crossref","unstructured":"Brunetti-Pierri N, Ng P. Gene therapy with helper-dependent adenoviral vectors: lessons from studies in large animal models. Virus Genes, (2017).","DOI":"10.1016\/B978-0-12-800276-6.00017-6"},{"key":"17180_CR44","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF03402113","volume":"6","author":"WK O\u2019Neal","year":"2000","unstructured":"O\u2019Neal, W. K. et al. Toxicity associated with repeated administration of first-generation adenovirus vectors does not occur with a helper-dependent vector. Molecular medicine \n                           6, 179\u2013195 (2000).","journal-title":"Molecular medicine"},{"key":"17180_CR45","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/43977","volume":"401","author":"S Lehrman","year":"1999","unstructured":"Lehrman, S. Virus treatment questioned after gene therapy death. Nature \n                           401, 517\u2013518 (1999).","journal-title":"Nature"},{"key":"17180_CR46","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1126\/science.286.5448.2244","volume":"286","author":"E Marshall","year":"1999","unstructured":"Marshall, E. Gene therapy death prompts review of adenovirus vector. Science \n                           286, 2244\u20132245 (1999).","journal-title":"Science"},{"key":"17180_CR47","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.1231143","volume":"339","author":"L Cong","year":"2013","unstructured":"Cong, L. et al. Multiplex genome engineering using CRISPR\/Cas systems. Science \n                           339, 819\u2013823 (2013).","journal-title":"Science"},{"key":"17180_CR48","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/978-1-60761-753-2_15","volume":"649","author":"DY Guschin","year":"2010","unstructured":"Guschin, D. Y. et al. A rapid and general assay for monitoring endogenous gene modification. Methods Mol Biol \n                           649, 247\u2013256 (2010).","journal-title":"Methods Mol Biol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-17180-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-17180-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-17180-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T10:23:33Z","timestamp":1671791013000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-17180-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,7]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["17180"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-17180-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,7]]},"assertion":[{"value":"28 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"17113"}}